240 related articles for article (PubMed ID: 19008943)
1. Genetic control of variegated KIR gene expression: polymorphisms of the bi-directional KIR3DL1 promoter are associated with distinct frequencies of gene expression.
Li H; Pascal V; Martin MP; Carrington M; Anderson SK
PLoS Genet; 2008 Nov; 4(11):e1000254. PubMed ID: 19008943
[TBL] [Abstract][Full Text] [Related]
2. Hematopoietic stem cell transplantation: Improving alloreactive Bw4 donor selection by genotyping codon 86 of KIR3DL1/S1.
Alicata C; Pende D; Meazza R; Canevali P; Loiacono F; Bertaina A; Locatelli F; Nemat-Gorgani N; Guethlein LA; Parham P; Moretta L; Moretta A; Bottino C; Norman PJ; Falco M
Eur J Immunol; 2016 Jun; 46(6):1511-7. PubMed ID: 26990677
[TBL] [Abstract][Full Text] [Related]
3. KIR3DL1 genetic diversity and phenotypic variation in the Chinese Han population.
Tao SD; He YM; Ying YL; He J; Zhu FM; Lv HJ
Genes Immun; 2014 Jan; 15(1):8-15. PubMed ID: 24173144
[TBL] [Abstract][Full Text] [Related]
4. KIR3DL1/S1 genotypes and KIR2DS4 allelic variants in the AB KIR genotypes are associated with Plasmodium-positive individuals in malaria infection.
Taniguchi M; Kawabata M
Immunogenetics; 2009 Dec; 61(11-12):717-30. PubMed ID: 19859704
[TBL] [Abstract][Full Text] [Related]
5. Allele diversity of the killer cell immunoglobulin-like receptors KIR3DL1/S1 and the combination with their HLA ligands in Mexican Mestizos from Mexico City.
González-Quezada BA; Sánchez-Fernández MGJ; Munguía-Saldaña AJ; Valencia-Macedo ME; Flores-Aguilar H; Bonilla-Galán E; Rodríguez-Gómez A; Díaz-Rivera A; Gorodezky C
Hum Immunol; 2018 Dec; 79(12):834-838. PubMed ID: 30365992
[TBL] [Abstract][Full Text] [Related]
6. HLA class I subtype-dependent expansion of KIR3DS1+ and KIR3DL1+ NK cells during acute human immunodeficiency virus type 1 infection.
Alter G; Rihn S; Walter K; Nolting A; Martin M; Rosenberg ES; Miller JS; Carrington M; Altfeld M
J Virol; 2009 Jul; 83(13):6798-805. PubMed ID: 19386717
[TBL] [Abstract][Full Text] [Related]
7. KIR3DS1-Specific D0 Domain Polymorphisms Disrupt KIR3DL1 Surface Expression and HLA Binding.
Mulrooney TJ; Zhang AC; Goldgur Y; Boudreau JE; Hsu KC
J Immunol; 2015 Aug; 195(3):1242-50. PubMed ID: 26109640
[TBL] [Abstract][Full Text] [Related]
8. Variable NK cell receptors exemplified by human KIR3DL1/S1.
Parham P; Norman PJ; Abi-Rached L; Guethlein LA
J Immunol; 2011 Jul; 187(1):11-9. PubMed ID: 21690332
[TBL] [Abstract][Full Text] [Related]
9. Functional polymorphism of the KIR3DL1/S1 receptor on human NK cells.
O'Connor GM; Guinan KJ; Cunningham RT; Middleton D; Parham P; Gardiner CM
J Immunol; 2007 Jan; 178(1):235-41. PubMed ID: 17182560
[TBL] [Abstract][Full Text] [Related]
10. Both the nature of KIR3DL1 alleles and the KIR3DL1/S1 allele combination affect the KIR3DL1 NK-cell repertoire in the French population.
Gagne K; Willem C; Legrand N; Djaoud Z; David G; Rettman P; Bressollette-Bodin C; Senitzer D; Esbelin J; Cesbron-Gautier A; Schneider T; Retière C
Eur J Immunol; 2013 Apr; 43(4):1085-98. PubMed ID: 23436464
[TBL] [Abstract][Full Text] [Related]
11. Association of the KIR3DS1*013 and KIR3DL1*004 alleles with susceptibility to ankylosing spondylitis.
Díaz-Peña R; Vidal-Castiñeira JR; Alonso-Arias R; Suarez-Alvarez B; Vicario JL; Solana R; Collantes E; López-Vázquez A; Martínez-Borra J; López-Larrea C
Arthritis Rheum; 2010 Apr; 62(4):1000-6. PubMed ID: 20131260
[TBL] [Abstract][Full Text] [Related]
12. HLA alleles determine differences in human natural killer cell responsiveness and potency.
Kim S; Sunwoo JB; Yang L; Choi T; Song YJ; French AR; Vlahiotis A; Piccirillo JF; Cella M; Colonna M; Mohanakumar T; Hsu KC; Dupont B; Yokoyama WM
Proc Natl Acad Sci U S A; 2008 Feb; 105(8):3053-8. PubMed ID: 18287063
[TBL] [Abstract][Full Text] [Related]
13. KIR3DS1/L1 and HLA-Bw4-80I are associated with HIV disease progression among HIV typical progressors and long-term nonprogressors.
Jiang Y; Chen O; Cui C; Zhao B; Han X; Zhang Z; Liu J; Xu J; Hu Q; Liao C; Shang H
BMC Infect Dis; 2013 Sep; 13():405. PubMed ID: 24059286
[TBL] [Abstract][Full Text] [Related]
14. Association of Functional Polymorphisms of KIR3DL1/DS1 With Behçet's Disease.
Castaño-Núñez Á; Montes-Cano MA; García-Lozano JR; Ortego-Centeno N; García-Hernández FJ; Espinosa G; Graña-Gil G; Sánchez-Bursón J; Juliá MR; Solans R; Blanco R; Barnosi-Marín AC; Gómez de la Torre R; Fanlo P; Rodríguez-Carballeira M; Rodríguez-Rodríguez L; Camps T; Castañeda S; Alegre-Sancho JJ; Martín J; González-Escribano MF
Front Immunol; 2019; 10():2755. PubMed ID: 31849952
[TBL] [Abstract][Full Text] [Related]
15. Unusual selection on the KIR3DL1/S1 natural killer cell receptor in Africans.
Norman PJ; Abi-Rached L; Gendzekhadze K; Korbel D; Gleimer M; Rowley D; Bruno D; Carrington CV; Chandanayingyong D; Chang YH; Crespí C; Saruhan-Direskeneli G; Fraser PA; Hameed K; Kamkamidze G; Koram KA; Layrisse Z; Matamoros N; Milà J; Park MH; Pitchappan RM; Ramdath DD; Shiau MY; Stephens HA; Struik S; Verity DH; Vaughan RW; Tyan D; Davis RW; Riley EM; Ronaghi M; Parham P
Nat Genet; 2007 Sep; 39(9):1092-9. PubMed ID: 17694054
[TBL] [Abstract][Full Text] [Related]
16. Donor KIR3DL1/3DS1 gene and recipient Bw4 KIR ligand as prognostic markers for outcome in unrelated hematopoietic stem cell transplantation.
Gagne K; Busson M; Bignon JD; Balère-Appert ML; Loiseau P; Dormoy A; Dubois V; Perrier P; Jollet I; Bois M; Masson D; Moine A; Absi L; Blaise D; Charron D; Raffoux C;
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1366-75. PubMed ID: 19822295
[TBL] [Abstract][Full Text] [Related]
17. Identification of bidirectional promoters in the human KIR genes.
Davies GE; Locke SM; Wright PW; Li H; Hanson RJ; Miller JS; Anderson SK
Genes Immun; 2007 Apr; 8(3):245-53. PubMed ID: 17315044
[TBL] [Abstract][Full Text] [Related]
18. The yin-yang of KIR3DL1/S1: molecular mechanisms and cellular function.
O'Connor GM; McVicar D
Crit Rev Immunol; 2013; 33(3):203-18. PubMed ID: 23756244
[TBL] [Abstract][Full Text] [Related]
19. Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism.
Gardiner CM; Guethlein LA; Shilling HG; Pando M; Carr WH; Rajalingam R; Vilches C; Parham P
J Immunol; 2001 Mar; 166(5):2992-3001. PubMed ID: 11207248
[TBL] [Abstract][Full Text] [Related]
20. Different and divergent regulation of the KIR2DL4 and KIR3DL1 promoters.
Stewart CA; Van Bergen J; Trowsdale J
J Immunol; 2003 Jun; 170(12):6073-81. PubMed ID: 12794136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
